Table of Contents Author Guidelines Submit a Manuscript
Anesthesiology Research and Practice
Volume 2013, Article ID 978615, 7 pages
http://dx.doi.org/10.1155/2013/978615
Review Article

Phenoxybenzamine in Complex Regional Pain Syndrome: Potential Role and Novel Mechanisms

Departments of Pharmacology and Anesthesiology, New York Medical College, Basic Sciences Building, Valhalla, NY 10595, USA

Received 29 August 2013; Accepted 15 November 2013

Academic Editor: Haibo Zhang

Copyright © 2013 Mario A. Inchiosa Jr. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Stanton-Hicks, W. Janig, S. Hassenbusch, J. D. Haddox, R. Boas, and P. Wilson, “Reflex sympathetic dystrophy: changing concepts and taxonomy,” Pain, vol. 63, no. 1, pp. 127–133, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. R. J. Schwartzman, G. M. Alexander, and J. Grothusen, “Pathophysiology of complex regional pain syndrome,” Expert Review of Neurotherapeutics, vol. 6, no. 5, pp. 669–681, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Merskey and N. Bogduk, “Descriptions of chronic pain syndromes and definitions of pain terms,” in Classification of Chronic Pain, pp. 40–43, IASP Press, Seattle, Wash, USA, 1994. View at Google Scholar
  4. P. J. Albrecht, S. Hines, E. Eisenberg et al., “Pathologic alterations of cutaneous innervation and vasculature in affected limbs from patients with complex regional pain syndrome,” Pain, vol. 120, no. 3, pp. 244–266, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. A. L. Oaklander, J. G. Rissmiller, L. B. Gelman, L. Zheng, Y. Chang, and R. Gott, “Evidence of focal small-fiber axonal degeneration in complex regional pain syndrome-I (reflex sympathetic dystrophy),” Pain, vol. 120, no. 3, pp. 235–243, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. T. C. Westfall and D. P. Westfall, “Adrenergic agonists and antagonists,” in Goodman and Gilman's, the Pharmacological Basis of Therapeutics, L. L. Brunton, Ed., pp. 267–268, McGraw-Hill, New York, NY, USA, 2006. View at Google Scholar
  7. C. Hamilton, H. Dalrymple, and J. Reid, “Recovery in vivo and in vitro of α-adrenoceptor responses and radioligand binding after phenoxybenzamine,” Journal of Cardiovascular Pharmacology, vol. 4, no. 1, supplement, pp. S125–S128, 1982. View at Google Scholar · View at Scopus
  8. T. N. Weingarten, J. P. Cata, J. F. O'Hara et al., “Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma,” Urology, vol. 76, no. 2, pp. 508–511, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. R. S. Perez, P. E. Zollinger, P. U. Dijkstra et al., “Evidence based guidelines for complex regional pain syndrome type 1,” BMC Neurology, vol. 10, article 20, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Cossins, R. W. Okell, H. Cameron, B. Simpson, H. M. Poole, and A. Goebel, “Treatment of complex regional pain syndrome in adults: a systematic review of randomized controlled trials published from June 2000 to February 2012,” European Journal of Pain, vol. 17, pp. 158–173, 2013. View at Google Scholar
  11. American Hospital Formulary Service, American Society of Health-System Pharmacists, Bethesda, Md, USA, 2013.
  12. D. S. Bennett and D. Brookoff, “Complex regional pain syndromes (reflex sympathetic dystrophy and causalgia) and spinal cord stimulation,” Pain Medicine, vol. 7, no. 1, pp. S64–S96, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. M. MOSER, A. G. PRANDONI, J. A. ORBISON, and T. W. MATTINGLY, “Clinical experience with sympathetic blocking agents in peripheral vascular disease,” Annals of Internal Medicine, vol. 38, no. 6, pp. 1245–1264, 1953. View at Google Scholar · View at Scopus
  14. S. Y. Ghostine, Y. G. Comair, and D. M. Turner, “Phenoxybenzamine in the treatment of causalgia. Report of 40 cases,” Journal of Neurosurgery, vol. 60, no. 6, pp. 1263–1268, 1984. View at Google Scholar · View at Scopus
  15. J. P. Muizelaar, M. Kleyer, I. A. M. Hertogs, and D. C. DeLange, “Complex regional pain syndrome (reflex sympathetic dystrophy and causalgia): management with the calcium channel blocker nifedipine and/or the α-sympathetic blocker phenoxybenzamine in 59 patients,” Clinical Neurology and Neurosurgery, vol. 99, no. 1, pp. 26–30, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. T. P. Lefkoe and D. D. Cardenas, “Reflex sympathetic dystrophy of the lower extremity in tetraplegia: case report,” Spinal Cord, vol. 34, no. 4, pp. 239–242, 1996. View at Google Scholar · View at Scopus
  17. V. K. Malik, M. A. Inchiosa Jr., K. Mustafa, M. Sanapati, M. C. Pimentel Jr., and E. A. M. Frost, “Intravenous regional phenoxybenzamine in the treatment of reflex sympathetic dystrophy,” Anesthesiology, vol. 88, no. 3, pp. 823–827, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. M. De Mos, M. C. J. M. Sturkenboom, and F. J. P. M. Huygen, “Current understandings on complex regional pain syndrome,” Pain Practice, vol. 9, no. 2, pp. 86–99, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. M. A. Inchiosa Jr. and G. Kizelshteyn, “Treatment of complex regional pain syndrome type I with oral phenoxybenzamine: rationale and case reports,” Pain Practice, vol. 8, no. 2, pp. 125–132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. R. N. Harden, S. Bruehl, M. Stanton-Hicks, and P. R. Wilson, “Proposed new diagnostic criteria for complex regional pain syndrome,” Pain Medicine, vol. 8, no. 4, pp. 326–331, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Baron and C. Maier, “Reflex sympathetic dystrophy: skin blood flow, sympathetic vasoconstrictor reflexes and pain before and after surgical sympathectomy,” Pain, vol. 67, no. 2-3, pp. 317–326, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. P. D. Drummond, S. Skipworth, and P. M. Finch, “α1-Adrenoceptors in normal and hyperalgesic human skin,” Clinical Science, vol. 91, no. 1, pp. 73–77, 1996. View at Google Scholar · View at Scopus
  23. W. Jänig and R. Baron, “Complex regional pain syndrome: mystery explained?” The Lancet Neurology, vol. 2, no. 11, pp. 687–697, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Wasner, J. Schattschneider, K. Heckmann, C. Maier, and R. Baron, “Vascular abnormalities in reflex sympathetic dystrophy (CRPS I): mechanisms and diagnostic value,” Brain, vol. 124, no. 3, pp. 587–599, 2001. View at Google Scholar · View at Scopus
  25. P. D. Drummond, P. M. Finch, S. Skipworth, and P. Blockey, “Pain increases during sympathetic arousal in patients with complex regional pain syndrome,” Neurology, vol. 57, no. 7, pp. 1296–1303, 2001. View at Google Scholar · View at Scopus
  26. R. N. Spengler, R. M. Allen, D. G. Remick, R. M. Strieter, and S. L. Kunkel, “Stimulation of α-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor,” Journal of Immunology, vol. 145, no. 5, pp. 1430–1434, 1990. View at Google Scholar · View at Scopus
  27. I. J. Elenkov, R. L. Wilder, G. P. Chrousos, and E. S. Vizi, “The sympathetic nerve—an integrative interface between two supersystems: the brain and the immune system,” Pharmacological Reviews, vol. 52, no. 4, pp. 595–638, 2000. View at Google Scholar · View at Scopus
  28. M. Weber, F. Birklein, B. Neundörfer, and M. Schmelz, “Facilitated neurogenic inflammation in complex regional pain syndrome,” Pain, vol. 91, no. 3, pp. 251–257, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. P. E. Molina, “Neurobiology of the stress response: contribution of the sympathetic nervous system to the neuroimmune axis in traumatic injury,” Shock, vol. 24, no. 1, pp. 3–10, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Bertini, S. Garattini, R. Delgado, and P. Ghezzi, “Pharmacological activities of chlorpromazine involved in the inhibition of tumour necrosis factor production in vivo in mice,” Immunology, vol. 79, no. 2, pp. 217–219, 1993. View at Google Scholar · View at Scopus
  31. N. Bloksma, F. Hofhuis, B. Benaissa-Trouw, and J. Willers, “Endotoxin-induced release of tumour necrosis factor and interferon in vivo is inhibited by prior adrenoceptor blockade,” Cancer Immunology, Immunotherapy, vol. 14, no. 1, pp. 41–45, 1982. View at Google Scholar · View at Scopus
  32. C.-J. Lo, I. Garcia, H. G. Cryer, and R. V. Maier, “Calcium and calmodulin regulate lipopolysaccharide-induced alveolar macrophage production of tumor necrosis factor and procoagulant activity,” Archives of Surgery, vol. 131, no. 1, pp. 44–50, 1996. View at Google Scholar · View at Scopus
  33. C. Q. Earl, W. C. Prozialeck, and B. Weiss, “Interaction of alpha adrenergic antagonists with calmodulin,” Life Sciences, vol. 35, no. 5, pp. 525–534, 1984. View at Publisher · View at Google Scholar · View at Scopus
  34. T. J. Lukas, D. R. Marshak, and D. M. Watterson, “Drug-protein interactions: isolation and characterization of covalent adducts of phenoxybenzamine and calmodulin,” Biochemistry, vol. 24, no. 1, pp. 151–157, 1985. View at Google Scholar · View at Scopus
  35. M. Chang, S. Smith, A. Thorpe, M. J. Barratt, and F. Karim, “Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mapping,” Molecular Pain, vol. 6, article 56, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Lamb, E. D. Crawford, D. Peck et al., “The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease,” Science, vol. 313, no. 5795, pp. 1929–1935, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. A. E. Te, “A modern rationale for the use of phenoxybenzamine in urinary tract disorders and other conditions,” Clinical Therapeutics, vol. 24, no. 6, pp. 851–861, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. O. Nettesheim, G. Höffken, M. Gahr, and M. Breidert, “Haematemesis and dysphagia in a 20-year-old woman with congenital spine malformation and situs inversus partialis,” Zeitschrift fur Gastroenterologie, vol. 41, no. 4, pp. 319–324, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Vaidyanathan, P. Mansour, B. M. Soni, P. L. Hughes, and G. Singh, “Chronic lymphocytic leukaemia, synchronous small cell carcinoma and squamous neoplasia of the urinary bladder in a paraplegic man following long-term phenoxybenzamine therapy,” Spinal Cord, vol. 44, no. 3, pp. 188–191, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. G. D. Friedman, S.-F. Jiang, N. Udaltsova, C. P. Quesenberry Jr., J. Chan, and L. A. Habel, “Epidemiologic evaluation of pharmaceuticals with limited evidence of carcinogenicity,” International Journal of Cancer, vol. 125, no. 9, pp. 2173–2178, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Goebel and F. Blaes, “Complex regional pain syndrome, prototype of a novel kind of autoimmune disease,” Autoimmunity Reviews, vol. 12, pp. 682–686, 2013. View at Google Scholar